 |
Urofollitropin |
|---|---|
| Trade Name | Metrodin |
| Orphan Indication | For induction of ovulation in patients with polycystic ovarian disease who have an elevated LH/FSH ratio and who have failed to respond to adequate clomiphene citrate therapy |
| USA Market Approval | USA |
| USA Designation Date | 1987-11-25 00:00:00 |
| Sponsor | EMD Serono, Inc.;One Technology Place;Roackland, Massachusetts, 02370 |
